LENZ Therapeutics (LENZ) News Today $29.33 -0.63 (-2.10%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$30.00 +0.67 (+2.28%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LENZ Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period TD Asset Management Inc Has $895,000 Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)1 hour ago | marketbeat.comQ3 EPS Forecast for LENZ Therapeutics Lifted by Analyst2 hours ago | americanbankingnews.comHC Wainwright Brokers Boost Earnings Estimates for LENZAugust 4 at 2:28 AM | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: LENZ Therapeutics (LENZ), GE Healthcare Technologies Inc (GEHC)August 3 at 8:05 PM | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: LENZ Therapeutics (LENZ) and Regeneron (REGN)August 3 at 8:05 PM | theglobeandmail.comResearch Analysts Offer Predictions for LENZ Q3 EarningsAugust 3 at 2:29 AM | americanbankingnews.comLENZ Therapeutics (NASDAQ:LENZ) Sees Strong Trading Volume on Analyst UpgradeAugust 2 at 11:29 AM | marketbeat.comNovel Eye Drops for Age-Related Blurry Vision Win FDA ApprovalAugust 2 at 8:26 AM | msn.comWilliam Blair Analysts Lower Earnings Estimates for LENZAugust 2 at 5:56 AM | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Sees Unusually-High Trading Volume Following Analyst UpgradeAugust 2 at 2:29 AM | americanbankingnews.comLENZ Therapeutics (NASDAQ:LENZ) Stock Price Expected to Rise, Raymond James Financial Analyst SaysAugust 1, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for LENZ FY2025 Earnings?August 1, 2025 | americanbankingnews.comLENZ Therapeutics Gains FDA Approval for VIZZ Eye DropJuly 31, 2025 | msn.comLenz (LENZ) Q2 Revenue Jumps 604%July 31, 2025 | theglobeandmail.comLenz Therapeutics Prepares for LNZ100 LaunchJuly 31, 2025 | msn.comLenz Therapeutics stock rises after FDA approves presbyopia eye dropsJuly 31, 2025 | za.investing.comLENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of PresbyopiaJuly 31, 2025 | globenewswire.comLENZ Therapeutics (NASDAQ:LENZ) Issues Quarterly Earnings ResultsJuly 31, 2025 | marketbeat.comFY2025 EPS Estimate for LENZ Therapeutics Boosted by AnalystJuly 31, 2025 | marketbeat.comLENZ Therapeutics shares climb as FDA review of presbyopia treatment stays on scheduleJuly 30, 2025 | msn.comLENZ Therapeutics shares surge as FDA review of presbyopia drug on trackJuly 30, 2025 | investing.comHC Wainwright Reaffirms Buy Rating for LENZ Therapeutics (NASDAQ:LENZ)July 30, 2025 | americanbankingnews.comLENZ Therapeutics: Undervalued Ahead Of PDUFAJuly 29, 2025 | seekingalpha.comLENZ Therapeutics gains on NDA submission in China for presbyopia drug LNZ100July 28, 2025 | msn.comLENZ Therapeutics (NASDAQ:LENZ) Shares Gap Up - What's Next?July 28, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for LENZ Therapeutics (NASDAQ:LENZ) Stock PriceJuly 28, 2025 | marketbeat.comLENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of PresbyopiaJuly 28, 2025 | globenewswire.comLENZ Therapeutics (NASDAQ:LENZ) Trading Down 6.6% - Time to Sell?July 26, 2025 | marketbeat.comDell, Bitfarms, Bloom Energy, and More Stocks See Action From Activist InvestorsJuly 25, 2025 | msn.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Recommendation of "Buy" by AnalystsJuly 21, 2025 | marketbeat.comLeerink Partnrs Has Bearish Outlook for LENZ FY2028 EarningsJuly 14, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 5.9% - Should You Sell?July 10, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Trading Up 8.7% - What's Next?July 9, 2025 | marketbeat.comLENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in CanadaJuly 7, 2025 | globenewswire.comLENZ Therapeutics: Presbyopia Eyedrops Look PromisingJuly 1, 2025 | seekingalpha.comLENZ Therapeutics Inc Dividends - MorningstarJuly 1, 2025 | morningstar.comMLisanti Capital Growth LLC Purchases New Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)June 30, 2025 | marketbeat.comLENZ - LENZ Therapeutics Inc Trailing Returns - MorningstarJune 28, 2025 | morningstar.comMLENZ Therapeutics Inc Financials - MorningstarJune 27, 2025 | morningstar.comMLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Buy" by BrokeragesJune 26, 2025 | marketbeat.comVersant sells LENZ therapeutics (LENZ) stock worth $10.1 millionJune 22, 2025 | investing.comLENZ Therapeutics: Ready To Test Its PotentialJune 16, 2025 | seekingalpha.comLENZ Therapeutics (NASDAQ:LENZ) Shares Up 6.3% - Here's WhyJune 11, 2025 | marketbeat.comTwo Sigma Investments LP Has $493,000 Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)June 10, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Shares Down 5.9% - Here's What HappenedJune 9, 2025 | marketbeat.comBank of America Corp DE Boosts Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)June 7, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Buy" by AnalystsJune 1, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Holdings Decreased by Ameriprise Financial Inc.June 1, 2025 | marketbeat.comLENZ Therapeutics May 2025 slides: presbyopia treatment nears FDA decisionMay 29, 2025 | uk.investing.comRafferty Asset Management LLC Purchases Shares of 17,716 LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 25, 2025 | marketbeat.com Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address LENZ Media Mentions By Week LENZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LENZ News Sentiment▼0.630.46▲Average Medical News Sentiment LENZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LENZ Articles This Week▼314▲LENZ Articles Average Week Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTCT News Today SWTX News Today MLTX News Today PTGX News Today AAPG News Today HCM News Today KYMR News Today CRNX News Today IMVT News Today ALVO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LENZ) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LENZ Stock Alerts